Related references
Note: Only part of the references are listed.Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Prevalence of idiopathic pulmonary fibrosis in Japan based on a claims database analysis
Yasuhiro Kondoh et al.
RESPIRATORY RESEARCH (2022)
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries
Abigel Margit Kolonics-Farkas et al.
FRONTIERS IN MEDICINE (2021)
Global incidence and prevalence of idiopathic pulmonary fibrosis
Toby M. Maher et al.
RESPIRATORY RESEARCH (2021)
Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry
Jing Gao et al.
RESPIRATORY RESEARCH (2021)
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Juergen Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
Paolo Cameli et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
Johanna Salonen et al.
PLOS ONE (2020)
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
Johanna Salonen et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials
Michael Kreuter et al.
RESPIRATORY RESEARCH (2020)
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
Laurie D. Snyder et al.
BMJ OPEN RESPIRATORY RESEARCH (2020)
y Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015
C. Magnus Skold et al.
RESPIRATORY MEDICINE (2019)
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
Jaana Kaunisto et al.
ERJ OPEN RESEARCH (2019)
Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis
Ryo Teramachi et al.
RESPIRATORY MEDICINE (2018)
Marked deterioration in the quality of life of patients with idiopathic pulmonary fibrosis during the last two years of life
K. Rajala et al.
BMC PULMONARY MEDICINE (2018)
Baseline clinical characteristics, comorbidities and prescribed medication in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
Wim A. Wuyts et al.
BMJ OPEN RESPIRATORY RESEARCH (2018)
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Andreas Guenther et al.
RESPIRATORY RESEARCH (2018)
Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Helen E. Jo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Burden of Idiopathic Pulmonary Fibrosis Progression: A 5-Year Longitudinal Follow-Up Study
Vincent Cottin et al.
PLOS ONE (2017)
Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report
Harold R. Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea
H-E. Lee et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
Luca Richeldi et al.
RESPIRATORY MEDICINE (2016)
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Juergen Behr et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
Jaana Kaunisto et al.
BMC PULMONARY MEDICINE (2015)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
Jaana Kaunisto et al.
BMC PULMONARY MEDICINE (2013)
Quality of the Finnish Hospital Discharge Register: A systematic review
Reijo Sund
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland
U Hodgson et al.
THORAX (2002)
Share Paper
